Description
+ Include: videos + file sub vtt + pdfs, size: GB
+ Target Audience: cardiologists, endocrinologists, internist, family medicine physicians, primary care physicians
+ Sample video: contact me for sample video
+ Information:
May 1 – 3, 2026
Immerse yourself in an educational experience at the 11th Annual Diabetes, Obesity, & Metabolic Disease Conference in New Orleans, Louisiana. Designed for healthcare professionals seeking the most current clinical insights, this conference offers a comprehensive agenda covering metabolic conditions, evidence-based approaches, and best practices for outpatient care. Engage with nationally acclaimed speakers and gain practical knowledge that can be immediately applied in your clinical setting.
Afternoons are yours to indulge in the treasures of the Big Easy. Easily explored by foot, the Sheraton New Orleans is just footsteps away from the Mississippi River, the National WWII Museum, Harrah’s Casino, the Aquarium of the Americas, the Shops at Canal Place, Royal Street, Bourbon Street, live jazz clubs, hundreds of award-winning restaurants, riverboat cruises, and a streetcar ride to the beautiful Garden District. Whether you’re networking with colleagues in a French Quarter courtyard or savoring a few moments of tranquility, the Diabetes, Obesity, & Metabolic Disease Conference promises an enriching blend of professional education and leisure in one of the most beautiful and interesting destinations in the country.
Our 2026 conference is perfectly timed with the world-renowned New Orleans Jazz & Heritage Festival. After a day of engaging education, step into the vibrant energy of live music, rich culture, and unforgettable cuisine. It’s the perfect opportunity to elevate your learning while immersing yourself in one of the most iconic celebrations in the country.
What Healthcare Professionals Are Saying
“This is the first course that might actually change my practice!”
Leslie K., MD
“Excellent conference! I never miss this one. This is my 5th year in a row. The speakers are the best.”
Michael A., MD
“Best conference I have attended. Great learning opportunity!”
Tamra P., NP
“CEC conferences far exceed other programs I have attended due to the quality of faculty, interactive format, locations/facilities and options for live stream or additional virtual post conference. I always come away with strong clinical pearls that I actually use to improve my patient care. Thanks.”
Nataki H., MD
“My first time attending in person conference and its absolutely terrific! Great platform to learn and know of updates in medical field. One of the most enticing part is 1/2 day conferences, hence allowing us to explore the city. Education and Entertainment in one place!”
Swetha Y., MD
“Attention grabbing information, new updates were current and research based.”
Sandra F., MD
Program Objectives
As a result of this conference, participants will be able to:
- Diagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.
- Integrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.
- Incorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.
Target Audience
This conference is designed for Physicians, Nurse Practitioners, Physician Assistants, and other related healthcare professionals involved in the treatment of patients at risk for cardiometabolic disorders.
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
- Day 1, May 1, 2026
- Day 2, May 2, 2026
- Day 3, May 3, 2026
* Detail:
FRIDAY, May 1, 2026
| Day 1: Diabetes, Cardio-Renal Disease Management with Cases, and MASLD/MASH with Case Studies | ||
| 7:50 am – 8:00 am | Welcome | A. Mullins, CHCP & J. Basile, MD |
| 8:00 am – 8:45 am | A Holistic Person-Centered Approach to Type 2 Diabetes Care | V. Aroda, MD |
| 8:45 am – 9:30 am | The Cardiovascular-Kidney-Metabolic Health Construct: Moving Away from Silos | J. Rangaswami, MD |
| 9:30 am BREAK | ||
| 9:45 am – 10:30 am | Exploration of Gut Hormone Drugs: Current Status and Pipeline | V. Aroda, MD |
| 10:30 am – 11:15 am | Combination Therapies in Kidney Disease: Saving Lives, Hearts, and Kidneys | J. Rangaswami, MD |
| 11:15 am – 11:30 am | Questions for Faculty | J. Rangaswami, MD & V. Aroda, MD |
| 11:30 am – 12:30 pm | Cases in Diabetes, Renal, and Cardio-Kidney Metabolic Disease | J. Rangaswami, MD & V. Aroda, MD |
| 12:30 pm LUNCH BREAK (Working Lunch) | ||
| 12:30 pm – 1:45 pm | Early identification and Management of Individuals At-Risk for MASH | F. Bril, MD |
| 1:45 pm – 2:45 pm | Clinical Decision Making in MASLD/MASH: A Case-Based Approach | F. Bril, MD |
SATURDAY, May 2, 2026
| Day 2: Comprehensive Obesity Management | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day One Review | J. Basile, MD |
| 8:00 am – 8:45 am | New Ways of Thinking About Obesity | D. Ryan, MD |
| 8:45 am – 9:30 am | Obesity: A Practical Guide to Diagnosis, Staging, and Front-Line Therapies | C. Still, MD |
| 9:30 am BREAK | ||
| 9:45 am – 10:30 am | Metabolic and Bariatric Surgery: Is it Still an Option? | C. Still, MD |
| 10:30 am – 11:15 am | Incretins and Nutrient Stimulating Hormone Targeted Meds – Weight Loss and Beyond | D. Ryan, MD |
| 11:15 am – 11:30 am | Questions for the Faculty | D. Ryan, MD & C. Still, MD |
| 11:30 am – 12:30 pm | Cases in Obesity Management | D. Ryan, MD & C. Still, MD |
SUNDAY, May 3, 2026
| Day 3: Hypertension and Dyslipidemia Management with Case Studies | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day Two Review | J. Basile, MD |
| 8:00 am – 9:00 am | Clinical Pearls in Outpatient HTN: What’s New in the 2025 HTN Guideline | J. Basile, MD |
| 9:00 am – 10:00 am | The 2026 Updated ACC/AHA Dyslipidemia Guideline: What’s New, What’s Not | L. Sperling, MD |
| 10:00 am BREAK | ||
| 10:15 am – 11:00 am | Focus on Lipid-Related Risk as a Component of Comprehensive Cardio-Kidney-Metabolic Health | L. Sperling, MD |
| 11:00 am – 11:15 am | Questions for the Faculty | J. Basile, MD & L. Sperling, MD |
| 11:15 am – 12:15 pm | Cases on HTN and Lipids | J. Basile, MD & L. Sperling, MD |
Reviews
There are no reviews yet.